Member Info for jonesrichard

So it's a nasal swab one? seems like a little more patience will be required until our one becomes the breaking news, not long to wait now fortunately, a matter of weeks, if not days.

There is a newer article from 6th May from the Yorkshire Post, please see link below:

https://www.yorkshirepost.co.uk/business/avacta-announces-good-progress-virus-tests-2844889

As you can see the company keep completing tasks much quicker than they expect so on that basis I suspect we will be hearing more on the test completion quite possible this week or latest the week after.

"If #AVCT do 1 billion tests around the world (partnerships / royalties / licenses) in 1 year that could be easily $5-10bn!!!

Even conservative estimates could see $1bn profit p/a considering Avct have themselves told us to think about a $13 markup. My figures are based on $5-10"

https://twitter.com/buy_buy_bye/status/1258889945944637442?s=20

Also if you read the following then it seems we could be looking at 1B-2 Billion profit per year and that could turn out to be conservative and just in the US alone! :

https://twitter.com/buy_buy_bye/status/1258889294636343298?s=20

https://www.nytimes.com/2020/04/29/health/coronavirus-saliva-spit-tests.html?algo=identity&fellback=false&imp_id=357782039&imp_id=647914159&action=click&module=Science%20%20Technology&pgtype=Homepage

" saliva test often yielded a stronger signal than the swab, suggesting that it is more sensitive — yielding fewer false negatives — than the swab. It also generated no false positives in all of the samples tested."

Fortunately our test eclipses any mentioned in the above article as ours can to used by anyone, anywhere and gives very fast results!

Yes Ken, thats a great idea, then any new investors who have questions can just be directed to your post which will then educate them on this company.

Of course, but this COVID situation is giving the company a lovely opportunity to get recognition in this field which will also bring in plenty of revenue for the Cancer treatment element of the business, basically it's a win win situation for the company right now moving forward which is why many feel that the sp is extremely undervalued currently!

If you research and watch the latest presentation then your doubts will be put to bed.

Covid-19 Vaccine is unlikely to prevent testing being a daily routine for global population -

"recent studies show that flu vaccination reduces the risk of flu illness by between 40% and 60% among the overall population "

AVCT winning solution IMO

https://twitter.com/SimonSaint3/status/1258845793957679104?s=20

And the following is the article from the tweet?

https://www.360dx.com/infectious-disease/rapid-antigen-assays-could-prove-key-addressing-sars-cov-2-testing-limitations#.XrWxXchKhPZ

Is this the tweet you are referring to?

https://twitter.com/360DxNews/status/1258803695229308932?s=20

I agree, once 'that confirmation RNS' hits the £5 + should be the new base here, the only reason we are currently at these levels is because the confirmation has yet to be made official but once it is then that will be the catalyst for a major sp re rate, we hope next week the confirmation will come but obviously could be the week after, either way just a little more patience required with regards to this issue.

That's good then Yorkshire, guessed it most probably wasn't up to the standards of our one but just thought I'd check, good to see that the saliva based tests are finally being shown to be the best. Everything looking very good now for holders here!

https://twitter.com/buy_buy_bye/status/1258795009995923458?s=20

That's correct, confirmation could come as early as next week, if not we should only be looking at a matter of a few weeks as opposed to months. All very exciting!

Seems like we are in desperate need of a quick, at home , saliva test!

https://www.dailymail.co.uk/news/article-8299967/Patients-tested-Covid-told-wait-10-days-results.html

It's 'you're'

XX

Yes it is correct that I am attempting to recoup my previous losses from that debacle, that doesn't negate the huge potential this company I am now invested in, I think I provide some fairly decent research to back up my optimism but you are entitled to our opinion sir. All the best to you.

Apologies Milk, I accept that I may have misinterpreted that link, apologies once again sir.

Lovely find wintzy, presumably that is us but for whatever reason they can not name us at this point maybe because there are still some i's to be tick and some t's to be crossed but it seems like the roll up is very very close now!

We are mention in the 'in development' section where it states:

"Avacta Group plc; Cytiva (formerly GE Healthcare Life Sciences), part of Danaher Corp. Rapid screening test Immunoassay Collaborating to develop and manufacture a point-of-care rapid test intended for screening of large populations to diagnose COVID-19; Avacta has generated Affimer reagents that that bind the SARS-CoV-2 viral antigen and Cytiva will transfer the diagnostic assay onto its point-of-care test strip platform"